Prostate cancer vaccines: the long road to clinical application Constantin N. BaxevanisMichael PapamichailSonia A. Perez Review 19 February 2015 Pages: 401 - 408
DNAM-1-based chimeric antigen receptors enhance T cell effector function and exhibit in vivo efficacy against melanoma Ming-Ru WuTong ZhangCharles L. Sentman Original Article 31 December 2014 Pages: 409 - 418
Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma Elias J. SayourPat McLendonDuane A. Mitchell Original Article 03 January 2015 Pages: 419 - 427
Inhibition of induced nitric oxide synthase enhances the anti-tumor effects on cancer immunotherapy using TLR7 agonist in mice Hiroyasu ItoTatsuya AndoMitsuru Seishima Original Article 08 January 2015 Pages: 429 - 436
Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008) Mario E. LacoutureJohn C. MorrisJoan Guitart Original Article 13 January 2015 Pages: 437 - 446
Enhancement of glioma-specific immunity in mice by “NOBEL”, an insulin-like growth factor 1 receptor antisense oligodeoxynucleotide Mélanie Morin-BrureauKirsten M. HooperD. Craig Hooper Original Article 13 January 2015 Pages: 447 - 457
The prognostic significance of stable disease following high-dose interleukin-2 (IL-2) treatment in patients with metastatic melanoma and renal cell carcinoma Tasha HughesMatthew KlairmontHoward L. Kaufman Original Article 22 January 2015 Pages: 459 - 465
Local expression of complement factor I in breast cancer cells correlates with poor survival and recurrence Marcin OkrojEmelie HolmquistAnna M. Blom Original Article 25 January 2015 Pages: 467 - 478
Strengthened tumor antigen immune recognition by inclusion of a recombinant Eimeria antigen in therapeutic cancer vaccination Dionisia QuirogaYasser A. AldhamenAndrea Amalfitano Original Article 06 February 2015 Pages: 479 - 491
Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer: dose-related immune boosting and suppression Masanori NoguchiGaku AraiKyogo Itoh Original Article 07 February 2015 Pages: 493 - 505
Low-dose cyclophosphamide enhances antigen-specific CD4+ T cell responses to NY-ESO-1/ISCOMATRIX™ vaccine in patients with advanced melanoma Oliver KleinIan D. DavisJonathan Cebon Original Article 07 February 2015 Pages: 507 - 518
“Tumor immunology meets oncology” (TIMO) X, May 23–24, 2014, Halle/Saale, Germany Dagmar QuandtBarbara Seliger Meeting Report 14 February 2015 Pages: 519 - 526